Pfizer

This Dec. 4, 2017, file photo shows the Pfizer company logo at the company's headquarters in New York.
Richard Drew / AP Photo

This is a developing story and may be updated.

Mylan Pharmaceuticals and a division of Pfizer have announced a deal that will create a new pharmaceutical company expected to bring in $19 billion-$20 billion in annual revenue. 

According to a news release, Mylan and Upjohn, the Pfizer subsidiary, hosted a Monday morning conference call with investors.

pills
Wikimedia Commons

A West Virginia Board of Pharmacy report says a prescription drug used to treat nerve pain is contributing to a sharp increase of overdose deaths in the state.

The Charleston Gazette-Mail reports the number of fatal overdoses involving gabapentin in West Virginia jumped from three in 2010 to 109 in 2015. The number of 2016 deaths are still being counted.